Infliximab-Associated Reversible Cholestatic Liver Disease
- 1 January 2001
- journal article
- case report
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 76 (1) , 84-86
- https://doi.org/10.4065/76.1.84
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Estrogens in intrahepatic cholestasis of pregnancyObstetrics & Gynecology, 2000
- Review article: safety of infliximab in clinical trialsAlimentary Pharmacology & Therapeutics, 1999
- DRUG- AND CHEMICAL-INDUCED CHOLESTASISClinics in Liver Disease, 1999
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1998
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997
- HEPATOTOXICITY OF CHEMOTHERAPEUTIC AND ONCOLOGIC AGENTSGastroenterology Clinics of North America, 1995
- Construction and initial characterization of a mouse-human chimeric anti-TNF antibodyMolecular Immunology, 1993